| Literature DB >> 28848439 |
Jiahang Sun1, Xiaoying Gao2, Dawei Meng3, Yang Xu4, Xichun Wang5, Xin Gu6, Mian Guo1, Xiaodong Shao7, Hongwen Yan8, Chuanlu Jiang1, Yongri Zheng1.
Abstract
The effects of the existing anti-epileptic drugs are unsatisfactory to almost one third of epileptic patients. MiR-134 antagomirs prevent pilocarpine-induced status epilepticus. In this study, a lithium chloride-pilocarpine-induced status epilepticus model was established and treated with intracerebroventricular injection of antagomirs targeting miR-134 (Ant-134). The Ant-134 treatment significantly improved the performance of rats in Morris water maze tests, inhibited mossy fiber sprouting in the dentate gyrus, and increased the survival neurons in the hippocampal CA1 region. Silencing of miR-134 remarkably decreased malonaldehyde and 4-hydroxynonenal levels and increased superoxide dismutase activity in the hippocampus. The Ant-134 treatment also significantly increased the production of ATP and the activities of mitochondrial respiratory enzyme complexes and significantly decreased the reactive oxygen species generation in the hippocampus compared with the status epilepticus rats. Finally, the Ant-134 treatment remarkably downregulated the hippocampal expressions of autophagy-associated proteins Atg5, beclin-1 and light chain 3B. In conclusion, Ant-134 attenuates epilepsy via inhibiting oxidative stress, improving mitochondrial functions and regulating autophagy in the hippocampus.Entities:
Keywords: autophagy; epilepsy; miR-134; mitochondrial functions; oxidative stress
Year: 2017 PMID: 28848439 PMCID: PMC5550691 DOI: 10.3389/fphar.2017.00524
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Sequences of primers.
| Genes | Sequence F (5′-3′) | Sequence R (5′-3′) | Size (bp) |
|---|---|---|---|
| mir-134 | GACTGGCTGTGAC TGGTTGACC | GTGCAGGGTCC GAGGTATTC | 63 |
| U6 | CTCGCTTCGGCA GCACA | AACGCTTCACGAATT TGCGT | 94 |
| Atg-5 | AGTGGAGGCAACAG AACCC | TCCGACCACCGTCAC CTTA | 250 |
| LC3B | CACAGTCTTTGTAAG GGCGGTTCT | GGCTTGCTTTAGTT GGAAGTGG | 145 |
| Beclin-1 | CAGCAGTTCAAAGA AGAGGTG | GAGGACACCCAAGC AAGAC | 235 |
| β-actin | GGAGATTACTGCCCT GGCTCCTAGC | GGCCGGACTCATCGT ACTCCTGCTT | 155 |